All In Biotech

Drug Trial Radar · NCT07822321

Brexanolone Lifting Outcomes Of Moms

A Randomized, Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral LPCN 1154A in Women With Postpartum Depression

Last checked: Nov 20, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Sep 2026

Primary completion

Aug 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Lipocine Inc.Industry
Sponsor type
Industry
First posted
Sep 16, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 15 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to test the study drug, LPCN 1154A, as a possible treatment for postpartum depression (PPD). The trial aims to determine: * If LPCN 1154A reduces depressive symptoms in subjects with severe PPD * How well LPCN 1154A is tolerated and what side effects it may cause

Conditions

  • Depression, Postpartum
  • Postpartum Depression (PPD)
  • Post-partum Depression
  • Postnatal Depression
  • Post-Natal Depression
  • Peripartum Depression

Interventions

  • LPCN 1154ADrug

    Oral LPCN 1154A tablets for 48 hours

  • PlaceboDrug

    Oral Placebo Tablets for 48 hours

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in HAM-D17 total score compared to placeboTime frame: Baseline to Hour 60

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • Lipocine Investigational Site

    Tucson, Arizona · Recruiting

  • Lipocine Investigational Site

    Canoga Park, California · Recruiting

  • Lipocine Investigational Site

    Walnut Creek, California · Recruiting

  • Lipocine Investigational Site

    Aurora, Colorado · Recruiting

  • Lipocine Investigational Site

    Decatur, Georgia · Recruiting

  • Lipocine Investigational Site

    Idaho Falls, Idaho · Recruiting

  • Lipocine Investigational Site

    Chicago, Illinois · Recruiting

  • Lipocine Investigational Site

    New Orleans, Louisiana · Recruiting

  • Lipocine Investigational Site

    Las Vegas, Nevada · Recruiting

  • Lipocine Investigational Site

    Princeton, New Jersey · Recruiting

  • Lipocine Investigational Site

    Manhattan, New York · Recruiting

  • Lipocine Investigational Site

    Chapel Hill, North Carolina · Recruiting

  • Lipocine Investigational Site

    Plano, Texas · Recruiting

  • Lipocine Investigational Site

    Richardson, Texas · Recruiting

  • Lipocine Investigational Site

    Clinton, Utah · Recruiting

  • Lipocine Investigational Site

    Orem, Utah · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.